Shikiar Asset Management Inc Regeneron Pharmaceuticals, Inc. Transaction History

Shikiar Asset Management Inc

$355 Million
Q3 2024

A detailed history of Shikiar Asset Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Shikiar Asset Management Inc holds 787 shares of REGN stock, worth $663,913. This represents 0.23% of its overall portfolio holdings.

Number of Shares

787

Previous 799 1.5%

Holding current value

$663,913

Previous $840,000 1.55%

% of portfolio

0.23%

Previous 0.23%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$1024.09 - $1201.76 $12,289 - $14,421	-12 Reduced 1.5%	787 $827,000
Q2 2024 Jul 16, 2024	SELL	$883.2 - $1071.19 $44,160 - $53,559	-50 Reduced 5.89%	799 $840,000
Q1 2024 Apr 22, 2024	BUY	$902.69 - $993.35 $9,929 - $10,926	11 Added 1.31%	849 $817,000
Q4 2023 Feb 01, 2024	SELL	$775.18 - $881.7 $829,442 - $943,419	-1,070 Reduced 56.08%	838 $736,000
Q3 2023 Oct 31, 2023	SELL	$692.45 - $844.37 $247,897 - $302,284	-358 Reduced 15.8%	1,908 $1.57 Million
Q2 2023 Jul 20, 2023	SELL	$700.03 - $830.35 $39,901 - $47,329	-57 Reduced 2.45%	2,266 $1.63 Million
Q1 2023 Apr 20, 2023	SELL	$680.49 - $826.97 $40,148 - $48,791	-59 Reduced 2.48%	2,323 $1.91 Million
Q3 2022 Oct 25, 2022	SELL	$573.97 - $724.32 $335,198 - $423,002	-584 Reduced 19.69%	2,382 $1.64 Million
Q2 2022 Jul 15, 2022	SELL	$548.35 - $738.84 $358,072 - $482,462	-653 Reduced 18.04%	2,966 $1.75 Million
Q1 2022 Apr 13, 2022	BUY	$595.12 - $698.43 $20,829 - $24,445	35 Added 0.98%	3,619 $2.53 Million
Q4 2021 Jan 21, 2022	SELL	$543.48 - $670.97 $186,413 - $230,142	-343 Reduced 8.73%	3,584 $2.26 Million
Q3 2021 Oct 29, 2021	BUY	$574.03 - $680.96 $1.1 Million - $1.31 Million	1,917 Added 95.37%	3,927 $2.38 Million
Q2 2021 Jul 16, 2021	BUY	$472.8 - $558.54 $185,810 - $219,506	393 Added 24.3%	2,010 $1.12 Million
Q1 2021 May 05, 2021	SELL	$446.73 - $548.2 $1.63 Million - $2 Million	-3,644 Reduced 69.26%	1,617 $765,000
Q4 2020 Feb 03, 2021	SELL	$478.3 - $607.98 $3.35 Million - $4.26 Million	-7,009 Reduced 57.12%	5,261 $2.54 Million
Q3 2020 Oct 28, 2020	BUY	$544.75 - $658.21 $1.79 Million - $2.17 Million	3,295 Added 36.71%	12,270 $6.87 Million
Q2 2020 Aug 20, 2020	BUY	$493.32 - $643.92 $4.43 Million - $5.78 Million	8,975 New	8,975 $5.6 Million

Others Institutions Holding REGN

# of Institutions

1,480

Shares Held

85.7M

Call Options Held

908K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $90.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shikiar Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Shikiar Asset Management Inc with notifications on news.

Account

Shikiar Asset Management Inc Regeneron Pharmaceuticals, Inc. Transaction History